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Abstract. 
 
Most receptor-like protein tyrosine phos-
phatases (PTPases) display a high degree of homology 
with cell adhesion molecules in their extracellular do-
mains. We studied the functional significance of pro-
cessing for the receptor-like PTPases LAR and PTP
 
s
 
. 
PTP
 
s
 
 biosynthesis and intracellular processing resem-
bled that of the related PTPase LAR and was ex-
pressed on the cell surface as a two-subunit complex. 
Both LAR and PTP
 
s 
 
underwent further proteolytical 
processing upon treatment of cells with either calcium 
ionophore A23187 or phorbol ester TPA. Induction of 
LAR processing by TPA in 293 cells did require over-
expression of PKC
 
a
 
. Induced proteolysis resulted in 
shedding of the extracellular domains of both PTPases. 
This was in agreement with the identification of a spe-
cific PTP
 
s
 
 cleavage site between amino acids Pro
 
821
 
 
and Ile
 
822
 
. Confocal microscopy studies identified adhe-
rens junctions and desmosomes as the preferential sub-
cellular localization for both PTPases matching that of 
plakoglobin. Consistent with this observation, we found 
direct association of plakoglobin and 
 
b
 
-catenin with the 
intracellular domain of LAR in vitro. Taken together, 
these data suggested an involvement of LAR and PTP
 
s
 
 
in the regulation of cell contacts in concert with cell ad-
hesion molecules of the cadherin/catenin family. After 
processing and shedding of the extracellular domain, 
the catalytically active intracellular portions of both 
PTPases were internalized and redistributed away from 
the sites of cell–cell contact, suggesting a mechanism 
that regulates the activity and target specificity of these 
PTPases. Calcium withdrawal, which led to cell contact 
disruption, also resulted in internalization but was not 
associated with prior proteolytic cleavage and shedding 
of the extracellular domain. We conclude that the sub-
cellular localization of LAR and PTP
 
s
 
 is regulated by 
at least two independent mechanisms, one of which re-
quires the presence of their extracellular domains and 
one of which involves the presence of intact cell–cell 
contacts. 
 
A
 
 key element in the regulation of cell–cell and cell–
matrix contacts is the tyrosine phosphorylation of
proteins that are localized in focal adhesions and
at intercellular junctions (for reviews see Kemler, 1993;
Clark and Brugge, 1995). While much is known about the
protein tyrosine kinases involved in the phosphorylation
of cell adhesion components, very little information exists
about the identity of protein tyrosine phosphatases (PTP-
ases),
 
1
 
 which are responsible for the dephosphorylation
and thereby regulation of these structural complexes.
Probable candidates are those receptor-like PTPases that
contain cell adhesion molecule-like extracellular domains
and could therefore regulate their intrinsic phosphatase
activity in response to cell contact. Recent reports suggest
that some PTPases do, in fact, possess properties that re-
semble those of classical cell adhesion molecules (for re-
view see Brady-Kalnay and Tonks, 1995). A direct in-
volvement in cell–cell contact has so far been demonstrated
for PTP
 
m
 
 (Brady-Kalnay et al., 1993; Gebbink et al., 1993)
and PTP
 
k
 
 (Sap et al., 1994), for which a homophilic inter-
action between their extracellular domains was found. The
localization of PTP
 
m
 
 (Brady-Kalnay et al., 1995; Gebbink
et al., 1995), PTP
 
k
 
 (Fuchs et al., 1996), and PCP-2 (Wang et
al., 1996) was restricted to sites of cell–cell contact and sur-
face expression of PTP
 
m
 
 (Gebbink et al., 1995), and PTP
 
k
 
(Fuchs et al., 1996) was increased in a cell density-depen-
dent manner. Moreover, a direct association of PTP
 
k
 
(Fuchs et al., 1996) and PTP
 
m
 
 (Brady-Kalnay et al., 1995)
with members of the cadherin/catenin family suggests that
proteins of the cell adhesion complex represent physiolog-
ical substrates for these PTPases. A possible regulatory
function in cell–matrix adhesion has been proposed for
LAR, another receptor-like PTPase, which associated with
focal cell–substratum adhesions via the newly identified
LAR interacting protein 1, LIP-1 (Serra-Pages et al., 1995).
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Abbreviations used in this paper
 
: GST, glutathione-S-transferase;
PTPase, protein tyrosine phophatase.
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PTP
 
m
 
 (Gebbink et al., 1991), PTP
 
k
 
 (Jiang et al., 1993;
Fuchs et al., 1996), PTP
 
d
 
 (Krueger et al., 1990; Mizuno et
al., 1993, Pulido et al., 1995
 
a
 
), PCP-2 (Wang et al., 1996),
and LAR (Streuli et al., 1988, Pot et al., 1991) are mem-
bers of the so-called type II receptor-like PTPases. The ex-
tracellular domains of these PTPases contain a variable
number of Ig-like and fibronectin type III-like (FNIII) do-
mains (for review see Charbonneau and Tonks, 1992).
With the exception of PCP-2 (Wang et al., 1996), these PTP-
ases also share characteristics in their biosynthesis. They
all underwent proteolytic processing by a furin-like en-
doprotease and were expressed at the cell surface in two
subunits which were not covalently linked (Streuli et al.,
1992; Yu et al., 1992; Jiang et al., 1993; Brady-Kalnay and
Tonks, 1994; Gebbink et al., 1995; Pulido et al., 1995
 
a
 
;
Fuchs et al., 1996). It was shown for LAR that the E sub-
unit, which contains the cell adhesion molecule-like extra-
cellular domain, was shed from the cell surface when cells
were grown to a high density (Streuli et al., 1992). This
shedding of the E subunit of LAR was the result of an ad-
ditional proteolytic processing step that could also be in-
duced by treatment of the cells with the phorbol ester
TPA (Serra-Pages et al., 1995). An accumulation of E sub-
units in the supernatant of cells was also observed for
PTP
 
m
 
 (Gebbink et al., 1995) and PTP
 
d
 
 (Pulido et al.,
1995
 
a
 
), and this suggests a common mechanism in the reg-
ulation of type II PTPases. However, the effect of pro-
teolytic processing on either the catalytic activity, the sub-
strate specificity, or the cellular localization of these
PTPases has not yet been determined. 
We report here that PTP
 
s
 
, a recently identified new
member of the family of receptor-like type II PTPases
(Pan et al., 1993; Walton et al., 1993; Yan et al., 1993;
Ogata et al., 1994; Zhang et al., 1994), underwent biosyn-
thesis and proteolytic processing in a manner that resem-
bled that of the most closely related PTPase LAR. More-
over, further proteolytic processing of PTP
 
s
 
 as well as of
LAR could be induced by treatment of the cells with TPA
or the calcium ionophore A23187. Transient expression
studies indicated that TPA-induced processing of LAR,
but not PTP
 
s
 
, was dependent on the coexpression of
PKC
 
a
 
. Inducible processing of both PTPases took place in
the extracellular segment of the P subunit in a juxtamem-
brane position and led to the shedding of the E subunit.
Both LAR and PTP
 
s
 
 were predominantly localized in re-
gions of cell–cell contact and accumulated in dot-like
structures that could be identified as adherens junctions
and desmosomes by colocalization with plakoglobin
(Cowin et al., 1986). Moreover, plakoglobin and 
 
b
 
-catenin,
another component of E-cadherin–containing cell adhe-
sion complexes in adherens junctions, associated directly
with the intracellular domain of LAR in vitro. The induc-
ible shedding of the E subunit of LAR and PTP
 
s
 
 was fol-
lowed by a redistribution of the PTPases within the cell
membrane and by an internalization of the cleaved P sub-
units. It therefore represents a mechanism through which
the phosphatase activity of these PTPases could be regu-
lated in response to cell–cell contact. The cell adhesion
molecule-like character of LAR and PTP
 
s
 
 was further
supported by the fact that the internalization of LAR and
PTP
 
s
 
 occurred independently of the proteolytic process-
ing if cells were grown in calcium-depleted growth me-
dium. The analogies in specific localization as well as inter-
nalization behavior of PTP
 
s
 
 and LAR, with molecules of
the cadherin/catenin family, strongly suggest a direct in-
volvement of PTP
 
s
 
 and LAR in the formation or mainte-
nance of intercellular contacts. 
 
Materials and Methods
 
Cell Lines and Culture Media
 
A431 (CRL 1555; American Type Culture Collection, Rockville, MD)
and HeLa (CCL 2; American type Culture Collection) cells were grown in
Dulbeco’s minimal essential medium (DMEM) containing 4.5 mg/ml glu-
cose and supplemented with 10% FCS. For growth of 293 cells (CRL
1573; American Type Culture Collection), DMEM containing 1.0 mg/ml
glucose and 10% FCS was used. All growth media were supplemented
with 2 mM 
 
l
 
-glutamine before use. For starvation experiments, A431 and
HeLa cells were grown for 48 h and 293 cells for 24 h in their respective
growth media, which were diluted 1:40 with identical serum-free medium.
All media and supplements were purchased from GIBCO BRL (Eggen-
stein, Germany).
 
cDNA Constructs
 
For transient expression experiments, the human LAR cDNA was cloned
into the cytomegalovirus early promoter-based (Eaton et al., 1986) ex-
pression plasmid pRK5. For subcloning purposes, pSP65–LAR was kindly
provided by H. Saito (Harvard Medical School, Boston, MA). pSP65–
LAR was cut with restriction enzymes EcoRI and NruI, and the two re-
sulting fragments of 4,448 (EcoRI/EcoRI) and 2,004 bp (EcoRI/NruI)
containing the complete coding region of human LAR were inserted in
the pRK5 plasmid, which had been linearized with restriction enzymes
EcoRI and EcoRV. The pRK5 expression plasmid containing the cDNA
of rat PTP
 
s
 
 (Yan et al., 1993) was kindly provided by Y. Schlessinger
(New York University Medical Center, New York).
The plasmid coding for the GST–hPTP LAR
 
i
 
 fusion protein was con-
structed by amplification of the cDNA sequence between amino acids
1,259 to 1,881 of human LAR using PCR with oligonucleotides 5
 
9
 
-CATG-
GATCCAAAAAGGAAAAGGACCCAC-3
 
9
 
 and 5
 
9
 
-GATCAGATCT-
TCACGTTGCATAGTGGTCAAAGC-3
 
9
 
. The PCR product was cut
with restriction enzymes BamHI and BglII and was inserted in the appro-
priate pGEX vector (Pharmacia Biotech, Uppsala, Sweden). Human
 
b
 
-catenin and plakogobin (these sequence data are available from Gen-
Bank/EMBL/DDBJ under accession number Z19054 and M23410, respec-
tively) were amplified from cDNA generated from MCF7 cells using the
PCR method and were cloned in pRK5 expression plasmid. The integrity
of subcloned PCR products was confirmed by sequence analysis. The
CMV-driven expression plasmid for PKC
 
a
 
 and rabbit antiserum 105 di-
rected against PKC
 
a
 
 were described elsewhere (Seedorf et al., 1995).
 
Antibodies
 
Rabbit antisera 
 
a
 
 LAR
 
EN
 
 and 
 
a
 
 LAR
 
EC
 
 were generated against synthetic
peptides corresponding to NH
 
2
 
 (amino acids 5–18) and COOH-terminal
(amino acids 1,129–1,142) regions of the LAR E subunit, respectively.
Rabbit antisera 320 and 322 were kindly provided by Y. Schlessinger
(New York University Medical Center, New York). Antiserum 320 is di-
rected against a peptide corresponding to the COOH-terminus of LAR
(amino acids 1868–1881) and PTP
 
s
 
 (amino acids 1465–1478), whereas an-
tiserum 322 is directed against a peptide corresponding to the NH
 
2
 
 termi-
nus of PTP
 
s
 
 (amino acids 5–18). Anti-plakoglobin (
 
g
 
-catenin) and anti-
 
b
 
-catenin antibodies were purchased from Transduction Laboratories
(Lexington, KY).
 
Transient Expression in 293 Cells and Stimulation
of Cells
 
293 cells were seeded in 20% confluency and were transfected 24 h later
using the calcium phosphate precipitation technique described by Chen
and Okayama (1987). 16 h after transfection, cells were washed once with
starvation medium (DMEM with 0.25% FCS) and grown for an additional
24 h in the same medium. Alternatively for metabolic labeling with
[
 
35
 
S]methionine, cells were washed and grown in methionine-free minimal 
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essential medium with 0.25% dialyzed FCS. 50 
 
m
 
Ci/ml [
 
35
 
S]methionine
(1,000 Ci/mmol, Amersham Intl., Amersham, UK) were added 16 h be-
fore lysis. Before lysis, cells were stimulated with 10
 
2
 
5
 
 M calcium iono-
phore A23187 (Sigma Chemical Co., Taufkirchen, Germany), 1 
 
m
 
M phor-
bol ester TPA (Sigma Chemical Co.), 5 mM EGTA, or 30 
 
m
 
M calpeptin
(Calbiochem, Bad Soden, Germany). Pervanadate was freshly prepared
from sodiumorthovanadate and H
 
2
 
O
 
2
 
 and was used in a final concentra-
tion of 0.1 mM Na
 
3
 
V0
 
4
 
 and 3 
 
3
 
 10
 
2
 
7
 
 M H
 
2
 
O
 
2
 
. Time intervals of incubation
are given in the figure legends.
 
Immunoprecipitation and Immunoblotting
 
Cells were washed once with ice-cold PBS and lysed in Triton X-100 lysis
buffer (50 mM Hepes, pH 7.2, 150 mM NaCl, 10% glycerol, 1% Triton
X-100, 100 mM NaF, 10 mM Na
 
4
 
P
 
2
 
O
 
7
 
, 2 mM Na
 
3
 
V0
 
4
 
, 5 mM EGTA, 1 mM
PMSF, 1 
 
m
 
g/ml each leupeptin, pepstatin, antipain, and chymostatin). Ly-
sates were centrifuged for 20 min at 12,500 
 
g
 
 to obtain the supernatant
fraction, and protein concentration was determined by using the method
described by Bradford (1976). Equal amounts of proteins were used in
each experiment. For immunoprecipitation, protein A-Sepharose (Phar-
macia Biotech) was preincubated with specific antisera, washed twice with
HNTG (50 mM Hepes, pH 7.2, 150 mM NaCl, 10% glycerol, 0.1% Triton
X-100, 1 mM Na
 
3
 
V0
 
4
 
, 1 mM PMSF), and added to the lysates. For binding
to WGA-Sepharose (Sigma Chemical Co.), lysates were diluted 1:5 in
HNTG and tissue culture supernatants centrifuged twice at 1,000 
 
g
 
 for 15
min before adding WGA-Sepharose. Glutathione-S-transferase (GST) fu-
sion proteins were expressed in 
 
Escherichia coli
 
 and purified as described
(Smith and Johnson, 1988). 3 
 
m
 
g of GST–hPTP LAR
 
i
 
 fusion protein and a
threefold molar excess of GST were incubated with equal amounts of cell
lysates and immobilized by adding glutathione–Sepharose (Sigma Chemi-
cal Co.). All immobilization steps were performed for 4–16 h, and the re-
sulting complexes were washed three times with HNTG. Samples were
boiled in SDS sample buffer for 10 min followed by separation in SDS-
PAGE. For immunoblotting analysis, the enhanced chemiluminescence
system (Amersham Intl.) was used in conjunction with goat anti–rabbit
antibodies (Bio Rad Labs). For reprobing purposes, blots were stripped in
62.5 mM Tris/HCl, pH 6.8, 2% SDS, and 100 mM 
 
b
 
-mercaptoethanol at
50
 
8
 
C for 1 h.
 
NH
 
2
 
-terminal Sequencing
 
PTP
 
s
 
 was expressed transiently in 293 cells, and the cells were incubated
for 1 h with 10
 
2
 
5
 
 M A23187 before lysis in Triton X-100 lysis buffer de-
scribed above, without the phosphatase inhibitors NaF, Na
 
4
 
P
 
2
 
O
 
7
 
, and
Na
 
3
 
V0
 
4
 
. Lysates of four 15-cm tissue culture plates were immunoprecipi-
tated with antiserum 320, immunprecipitates separated in 8% SDS-
PAGE, and transferred to ProBlot™-membrane (Applied Biosystems).
Proteins were stained with Coomassie blue R-250, and the processing
product of the PTP
 
s
 
 P subunit was isolated. Microsequencing was per-
formed by using a sequencer (model 494; Applied Biosystems) using stan-
dard reagents and programs as suggested by the manufacturer.
 
Immunofluorescence Microscopy
 
For immunofluorescence studies, A431 cells (CRL 1555; American Type
Culture Collection) were grown for 48 h on uncoated glass coverslips to
different degrees of confluency. Control cells or cells incubated with ei-
ther TPA, EGTA, or ionophore for the respective time intervals (see Figs.
7–10, legends) were fixed with 2% formaldehyde freshly prepared from
paraformaldehyde in PBS (pH 7.4, 0.12 M sucrose). Autofluorescence was
quenched with PBS glycine (100 mM), and the cells were permeabilized
with 0.5% saponin in PBS (5 min). Unspecific antibody binding was
blocked for 1 h with phosphate buffered gelatine (PBG: PBS, 0.5% bovine
serum albumin, 0.045% cold-water fish gelatine). Primary antibody incu-
bation was done at room temperature for 2 h after dilution in PBG, 1:50
for rabbit antisera 
 
a
 
 LAR
 
EN
 
, 320, and 322, and 1:200 for monoclonal anti-
plakoglobin antibody. After three washes in PBG, primary antibody binding
was detected with isotype-specific secondary antibody, FITC(DTAF)-
conjugated donkey-anti–rabbit IgG (1:200), or Cy3-conjugated goat-anti–
mouse IgG (1:300; Jackson ImmunoResearch Laboratories, West Grove,
PA). For double labeling experiments, antibody decoration was done con-
secutively. Controls were incubated with either species-specific nonim-
mune serum or with secondary antibody alone. Coverslips were mounted
under glycerol–2.4% Dabco (1,4 Diazabicyclo [2.2.2*octane]) and were
viewed with appropriate band pass filters on a laser confocal microscope
(LSM 410; Carl Zeiss, Oberkochen, Germany) using a 40
 
3
 
 oil immersion
objective of aperture 1.3. Images were recorded with a voxel size of 0.082
mm and smoothed for printouts by subdividing the pixels and linear inter-
polation. Controls were recorded at identical settings. To visualize the lo-
calization of antibody binding together with the cellular morphology, a
gray scale transmission image (pseudo-phase contrast) and the two confo-
cal fluoresence images (FITC and Cy3) were superimposed in AVS (Ad-
vances Visual Systems, Waltham, MA).
 
Scanning Electron Microscopy
 
For scanning electron microscopy, cells were fixed with 2% formaldehyde/
1% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4, 0.12 M sucrose on
ice), postfixed with 0.02 M osmium tetroxide for 30 min, flushed with 30%
ethanol, and dehydrated through graded ethanol and 100% dried acetone.
After critical point drying with CO
 
2
 
 for 60 min (Polaron, Watford, UK) the
coverslips were attached to scanning electron microscopy stubs with con-
ductive carbon paint and left overnight. Before examination on a scanning
electron microscope (35; Jeol, Tokyo, Japan) they were gold sputtered to
a thickness of 20 nm (SCD 020 Coating Unit; Balzers, Liechtenstein).
 
Results
 
Biosynthesis and Processing of LAR and PTP
 
s
 
LAR and PTP
 
s
 
 are highly related PTPases whose rat ho-
mologues display a sequence identity of 79% in their prox-
imal membrane PTPase domain, 90% in their COOH-ter-
minal PTPase domain, and 57% in their extracellular
domain (Zhang et al., 1994). LAR contains three Ig- and
eight FNIII-like domains in the extracellular domain and
two intracellular PTPase domains. Three splice variants of
PTP
 
s
 
 are known so far. The rat protein we analyzed (Pan
et al., 1993; Walton et al., 1993; Yan et al., 1993) differs
from LAR in so far as it lacks the FNIII-like domains four
through seven. While it was shown that LAR was ex-
pressed in two subunits (Streuli et al., 1992; Yu et al.,
1992), the biosynthesis of PTP
 
s
 
 has not yet been studied.
We hypothesized that PTP
 
s
 
 would be processed in a man-
ner that is analogous or similar to the processing of LAR
because a polyclonal antiserum directed against one of its
FNIII-like domains recognized a protein of 
 
z
 
100 kD in-
stead of the 168 kD that would have been predicted from
the full length sequence of PTP
 
s
 
 (Yan et al., 1993; Rotin
et al., 1994). Fig. 1 
 
A
 
 shows the schematic structure of
LAR and PTP
 
s
 
, the proposed biosynthesis of PTP
 
s
 
, and
the recognition sites of subunit-specific antibodies used in
this study.
To compare the biosynthesis of human LAR and rat
PTP
 
s
 
, both proteins were transiently expressed in human
embryonic kidney 293 cells (Fig. 1, 
 
B
 
 and C). As shown in
Fig. 1 B, antiserum (320) directed against the identical
COOH terminus of human LAR and rat PTPs recognized
proteins of 205 and 84 kD in cell lysates of LAR express-
ing 293 cells and proteins of 158 and 80 kD in PTPs-
expressing 293 cells. These protein bands represented the
precursor and the proteolytically processed P subunits of
both PTPases, respectively. The reduced size of the PTPs
precursor and E subunit of 40 kD was in good agreement
with the presence of only four FNIII-like domains instead
of eight such domains in LAR. The molecular mass of the
P subunit of PTPs, on the other hand, varied only by 4 kD.
The large amount of unprocessed precursor protein that
was detected is most likely the result of overexpression in
the 293 cell system.The Journal of Cell Biology, Volume 138, 1997 684
The proteins immunoprecipitated with the same antise-
rum from [35S]methionine-labeled cells were identical
(Fig. 1 C). As previously demonstrated with LAR (Streuli
et al., 1992; Yu et al., 1992), the noncovalent linkage be-
tween the E and P subunit was stable under standard cell
lysis conditions and during immunoprecipitation. The
LAR E subunit of 150 kD could thus be coimmunoprecip-
itated with the antiserum directed against the P subunit
(Fig. 1 C). For PTPs, a coimmunoprecipitated 97-kD pro-
tein (Fig. 1 C) was identified as its processed extracellular
domain by immunoblot analysis with an antiserum raised
against an NH2-terminal peptide (Fig. 1 B). Taken to-
gether, these data show that the biosynthesis of PTPs is in-
deed comparable to that of LAR in every aspect (Fig. 1 A).
When 293 cells that overexpressed the PTPases were
treated with the calcium ionophore A23187 before lysis,
additional proteins of 70 (LAR) and 72 kD (PTPs) could
be immunoprecipitated with the COOH terminus-specific
consensus antiserum 320. In addition, the amount of im-
munoprecipitated P and E subunits was considerably re-
duced, whereas the amount of immunoprecipitated pre-
cursor of both PTPases was not or much less affected (Fig.
1 C). Immunoblot studies using specific antisera directed
against the E and P subunit indicated that the 70- and 72-
kD proteins were derived from the P subunits of LAR and
PTPs, respectively, by proteolytic processing at the NH2
terminus (Fig. 1 B). Since coimmunoprecipitation of the E
subunits with the shortened P subunits was not detected
(Fig. 1 C), proteolytic processing induced by calcium iono-
phore treatment resulted in separation of the E and the P
subunit. This lack of association between the E subunit
and the shortened P subunit could also be demonstrated
by analyzing the binding of subunits of LAR and PTPs to
WGA (Fig. 1 B). In untreated cells, the P subunits of LAR
and PTPs were found enriched in the fraction of WGA-
bound proteins. However, after processing was induced,
the 70- and 72-kD protein bands were no longer detected
in the WGA-bound protein fraction (Fig. 1 B). This indi-
Figure 1. Physiological- and calcium ionophore-induced processing of LAR and PTPs after transfection into 293 cells. (A) Schematic
representation of the biosynthesis of LAR and PTPs. Dashed lines indicate a gap introduced for alignment purposes. Antibody 320 spe-
cifically recognizes the P subunit, while a LAREC and 322 recognize the E subunits of LAR and PTPs, respectively. (B) LAR or PTPs
were transiently expressed in 293 cells and before lysis cells were treated for 1 h with or without 1025 M A23187, as indicated. Control
cells were transfected with the expression plasmid pRK5. Lysates were either separated by 8% SDS-PAGE (TRITON) or after binding
to WGA–sepharose beads. Proteins were transferred to nitrocellulose and analyzed by immunoblotting of the membrane with antisera
specific for the COOH terminus of LAR and PTPs (320), the NH2 terminus of PTPs (322), or the COOH terminus of the LAR E sub-
unit (aLAREC). Arrows on the left indicate molecular weight standards, and arrows on the right indicate the position of the LAR and
PTPs subunits. (C) 293 cells transfected with LAR, PTPs, or control plasmid were labeled with [35S]methionine (16 h) and incubated
with or without A23187, as described above. Lysates were immunoprecipitated with antiserum specific for LAR and PTPs (320) or with
nonimmune serum (NI). Immunoprecipitates were separated by 8% SDS-PAGE, and the dried gel was exposed to X-ray film for 24 h.
Arrows on the left indicate molecular weight and on the right the position of the P subunits of LAR and PTPs, respectively.Aicher et al. PTPs and LAR Processing 685
cates that the P subunits would have to be linked to their
respective E subunits to be detected in the WGA-bound
protein fraction.
The antiserum specific for the COOH terminus of the
PTPases recognized an additional protein of 76 kD in 293
cells that expressed PTPs. The relative amount of this pro-
tein varied from experiment to experiment and was not af-
fected by calcium ionophore treatment of the cells (Fig. 1,
B and C). It therefore most likely represents a degradation
product of PTPs, although a different type of processing
cannot be excluded. An equivalent protein product, how-
ever, could not be detected in 293 cells that expressed LAR. 
Involvement of PKCa in the Proteolytic Processing of 
LAR and PTPs
Proteolytic processing of transmembrane proteins could
be shown to depend on the activation of PKCa in several
instances (for review see Ehlers and Riordan, 1991). We
therefore investigated whether treatment of LAR and
PTPs overexpressing 293 cells with the PKCa activator TPA
(12-O-tetradecanoylphorbol–13-acetate) could induce pro-
teolytic processing of these PTPases. In addition we analy-
sed if this processing is dependent on the coexpression of
PKCa in these cells. 293 cells were transfected with vec-
tors encoding LAR or PTPs alone or together with a PKCa
expression plasmid. The effect of TPA treatment of these
cells on the proteolytic processing of the PTPases was de-
termined by immunoblotting of cell lysates with the COOH
terminus-specific antiserum 320 (Fig. 2, top gel). The reprob-
ing of the same membrane with an antiserum specific for
PKCa confirmed comparable expression levels of PKCa
(Fig. 2, bottom gel). For immunoblotting we used smaller
quantities of cell lysate from cells that expressed only the PTP-
ases, because coexpression of PKCa consistently reduced
the amount of LAR and PTPs expression in these cells.
As shown in Fig. 2, induced processing of overexpressed
LAR in 293 cells occurred only when PKCa was coex-
pressed. This indicated a critical involvement of this enzyme
in the TPA-induced processing of LAR. PTPs processing in
response to TPA, on the other hand, was independent of
PKCa overexpression in 293 cells. We cannot exclude that
this effect was mediated by endogenous PKCa and may be
due to a higher susceptibility of PTPs towards TPA-induced
processing in comparison to LAR.
In TPA-treated cells the P subunits of LAR, whether
processed or unprocessed, showed a shift to a higher mo-
lecular weight in comparison to nontreated cells or to cells
in which processing was induced by calcium ionophore
(Fig. 2). In contrast to the TPA-induced proteolytic pro-
cessing of LAR, this shift to a higher molecular weight of
the noncleaved P subunit occured even in the absence of
overexpressed PKCa and was most likely mediated by en-
dogenous PKCa. We assume that the increase in molecu-
lar weight was due to a modification of the LAR P sub-
units by serine/threonine phosphorylation because we
observed TPA-dependent [32P]orthophosphate incorpora-
tion in PKCa coexpressing 293 cells (data not shown). A
shift to higher molecular weight for the P subunits of
PTPs, however, was not observed (Fig. 2) although TPA-
induced [32P]orthophosphate incorporation in the P sub-
units of PTPs was comparable to LAR (data not shown).
Processing of LAR and PTPs in HeLa, A431, and
293 Cells
In human platelets, cytosolic PTP1B was proteolytically
processed after treatment with A23187 and TPA. This
processing occurred in a calcium-dependent manner and
was mediated by the intracellular protease calpain (Fran-
gioni et al., 1993). Therefore, we studied the calcium de-
pendence as well as the influence of a specific calpain in-
hibitor, calpeptin (Tsujinaka et al., 1988), on the proteolytic
processing of LAR and PTPs (Fig. 3). Accordingly, A431,
HeLa cells, and nontransfected 293 cells were treated with
the calcium ionophore A23187 or with TPA. Cells that
were treated with A23187 were preincubated either with
calpeptin or with an excess of EGTA to deplete the me-
dium of calcium. Lysates of the cells were immunoprecipi-
tated with antiserum 320 and immunoprecipitates ana-
lyzed in immunoblots with antiserum 320 and antiserum
aLAREC (Fig. 3).
In the cell lines, we examined the expression of PTPs
with E subunit-specific (data not shown in Fig. 3; see Fig.
5) as well as P subunit-specific antisera could be clearly de-
tected only in A431 cells, whereas all three cell lines ex-
press LAR (Fig. 3). Ionophore-induced proteolytic pro-
cessing led in all cell lines to protein products of the same
molecular weight. Pretreatment with EGTA eliminated
the appearance of the proteolytic products, suggesting that
proteolysis was indeed calcium dependent. However, pre-
treatment with the calpain inhibitor calpeptin had no ef-
fect, thereby indicating that calpain was not required for
Figure 2. Effect of TPA treatment and coexpression of PKCa on
the processing of LAR and PTPs in 293 cells. LAR or PTPs were
transiently expressed in 293 cells either alone or together with
PKCa. As controls, pRK5 plasmid or PKCa expressing cells were
used. Before lysis, cells were treated for 1 h with or without 1 mM
TPA or 1025 M A23187 as indicated. Lysates were separated by
7% SDS-PAGE (TRITON), proteins were transferred to nitro-
cellulose and subsequently analyzed by immunoblotting of the
same membrane with antisera specific for the COOH terminus of
LAR and PTPs (320) and PKCa (105). The amount of cell ly-
sates analyzed is one third in LAR/pRK5-transfected cells and
one half in PTPs/pRK5 transfected cells in comparison to lysates
in the other lanes. Sizes of molecular weight standards in kD are
indicated on the left.The Journal of Cell Biology, Volume 138, 1997 686
this proteolytic effect. A control experiment using PTP1B
transiently expressed in 293 cells showed that the same
concentration of calpeptin could inhibit PTP1B processing
almost completely (data not shown). This confirmed that,
although the ionophore-induced processing of LAR and
PTPs was calcium dependent, it was not mediated by calpain.
In agreement with the results obtained with 293 cells
(Fig. 2), the treatment of cells with TPA resulted in pro-
teolytic processing and differed from the one induced by
ionophore treatment, since it caused a shift of the P sub-
units as well as the processing products to a higher molec-
ular weight. As opposed to overexpressed LAR in 293
cells (Fig. 2), the inducible processing of endogenous LAR
by TPA treatment in the same cells as well as in HeLa and
A431 cells occurred without transfection of PKCa and is
therefore most likely mediated by the endogenous enzyme
in these cells. As seen with the ionophore, TPA-induced
processing occurred at the NH2 terminus of the P subunits
and cleaved the linkage between the E and the P subunits
(Fig. 3). Moreover, treatment with A23187 and TPA
induced an identical proteolytic processing in SK-BR-3,
BT-20, MIA-PaCa-2, and PC12 cells (data not shown).
This suggested that this inducible proteolytic processing
pattern is a general feature of LAR and PTPs and occurs
independently of cell type.
Time Course of LAR and PTPs Processing in A431 and 
HeLa Cells
We performed a time course study to compare calcium
ionophore and TPA-induced processing of LAR and
PTPs in different cell lines. HeLa and A431 cells were in-
cubated for different time periods with A23187 and TPA
before lysis, and immunoprecipitates with antiserum 320
were analyzed by immunoblotting with the same antise-
rum. As shown in Fig. 4, in A431 cells the processing was
complete after 10–20 min of ionophore treatment and
even on the longest exposures of the immunoblot, the P
subunits of the PTPases could not be detected (data not
shown). In contrast, in HeLa cells, the processing of LAR
was maximal but incomplete after 40 min of treatment and
could not be increased further by longer incubation times. 
The TPA-induced processing was comparable in both
cell lines. Proteolytic processing of both PTPases was max-
imal after z40 min and could not be increased further. In
A431 cells especially, the lower molecular weight P sub-
unit was affected by TPA treatment. Since the data shown
in Fig. 2 already indicated a greater susceptibility of PTPs
to TPA-induced processing, the higher and lower molecu-
lar weight bands in A431 cells most likely represented the
LAR and PTPs P subunits, respectively.
It is noteworthy that TPA as well as ionophore treat-
ment for up to 2 h caused the appearance of the same pro-
cessing products observed after short time treatment. The
absence of any additional degradation products after long-
term incubation supported the conclusion that proteolytic
processing of LAR and PTPs was a specific and therefore
functionally significant event.
Inducible Shedding of LAR and PTPs-E subunits in 
A431 Cells 
For further characterization, we determined the position
of the site where the inducible proteolytic processing takes
place. The calculated molecular weight of the intracellular
domains and the transmembrane regions of both PTPases
was 74 kD. Because the molecular weight of the process-
ing products of the P subunits was 72 and 70 kD (Fig. 1),
cleavage most likely occurred within or near the trans-
membrane region. To determine whether cleavage oc-
curred in the extra- or intracellular part of the P subunits
we performed the following experiments. A431 cells were
Figure 4. Time course of inducible processing of LAR and PTPs
in HeLa and A431 cells. A431 and HeLa cells were starved for 2 d
and then incubated for different time intervals (indicated in min)
with A23187 (1025 M) or TPA (1 mM). Control cells were incu-
bated with vehicle, which is indicated as E (ethanol) and D
(DMSO). Cell lysates (0.9 mg protein) were immunoprecipitated
with antiserum specific for LAR and PTPs (320) or nonimmune
serum (NI). Immunoprecipitates were separated by 8% SDS-
PAGE, transferred to nitrocellulose, and analyzed by immuno-
blotting with antiserum specific for the COOH terminus of LAR
and PTPs (320). Arrows at the left indicate the position of the
processing products of the P subunit of LAR and PTPs.
Figure 3. Characteristics of inducible processing of LAR and
PTPs in different cell lines. HeLa, A431, and 293 were incubated
with or without A23187 (1025 M, 1 h) or TPA (1 mM, 1 h) or were
pretreated with EGTA (5 mM, 1h) or calpeptin (30 mM, 1 h). Cell
lysates (1.2 mg protein) were immunoprecipitated with either anti-
serum specific for LAR and PTPs (320) or nonimmune serum
(NI). Immunoprecipitates were separated by 8% SDS-PAGE,
transferred to nitrocellulose, and analyzed by immunoblotting of
the membrane with antiserum specific for the COOH terminus of
LAR and PTPs (320) or the COOH terminus of the LAR E sub-
unit (aLAREC).Aicher et al. PTPs and LAR Processing 687
treated with vehicle, A23187, or TPA before lysis. Cell ly-
sates were immunoprecipitated with antiserum 320, and
glycosylated proteins were bound to WGA–Sepharose. In
parallel, glycosylated proteins from the supernatants of
the same cells were enriched by binding to WGA–
Sepharose. The presence of LAR and PTPs subunits in
the different fractions was analyzed by subsequent immu-
noblotting with antibodies directed against the different
subunits (Fig. 5). As shown in Fig. 5, the E subunits of
LAR and PTPs were no longer present in the fraction of
WGA-bound proteins after induced proteolytic process-
ing. Instead, they could be detected in the supernatant.
This demonstrated that the cleavage site for induced pro-
teolytic processing was located in the extracellular domain
of the P subunit and that processing caused shedding of
the E subunits of LAR and PTPs. As shown earlier, the
lower molecular weight band that was recognized by the
antibody directed against the COOH terminus of the PTPases
was found to be more sensitive to TPA-induced processing
(Fig. 4). Because the corresponding E subunit found in the
supernatant was recognized by an antiserum specific for
PTPs, the lower molecular weight subunit was now identi-
fied as the P subunit of PTPs.
Shedding of the E subunits of the PTPases could not be
observed in overexpressing 293 cells, even though cleav-
age of the P subunits resulted in loss of the linkage be-
tween E and P subunits (Fig. 1, B and C) comparable to
other cell lines (Fig. 3 and 5). This fact is most likely due to
inhibition of solubilization of the E subunits by the cal-
cium precipitation technique used for transfection of the
cells.
Proteolytic Cleavage Site of PTPs
Because the inducible processing of LAR and PTPs was
identical in cell lines that endogenously express the phos-
phatases and in transfected 293 cells, we used the 293 cell
overexpression system to isolate the processed P subunit
of PTPs and to determine the cleavage site by NH2-termi-
nal sequence analysis. The NH2-terminal sequence (XVD-
GEEGLI) of the ionophore-induced processing product
of PTPs was identical to amino acids 822-830 of PTPs,
with exception of the first amino acid (X) which could not
be identified (Fig. 6). The cleavage occurred extracellulary
between amino acids Pro821 and Ile822, only six amino acids
away from the transmembrane region. In this region the
protein sequence of LAR does not show a significant ho-
mology to the sequence of PTPs, and the proteolytic
cleavage site of LAR is therefore not necessarily in an
analogous position to that of PTPs. The data in Fig. 5,
however, indicated that the inducible processing of LAR
also took place in the extracellular part of the P subunit.
Figure 5. Shedding of LAR and PTPs E subunits in A431 cells.
A431 cells were starved for 2 d, washed once with starvation me-
dium, and treated with or without A23187 (1025 M, 1 h) or TPA
(1 mM, 40 min). Cell lysates (TRITON) were either immunopre-
cipitated with antiserum specific for LAR and PTPs (IP:320, 0.9
mg protein) or were bound to WGA-sepharose beads (WGA, 0.6
mg protein). Proteins of the tissue culture supernatant of these
cells (MEDIUM, corresponding to 1.5 mg protein of cell lysate)
were bound to WGA-sepharose beads (WGA). Immunoprecipitates
and WGA-bound proteins were separated by 8% SDS-PAGE,
transferred to nitrocellulose, and analyzed by immunoblotting of
the membrane with antiserum specific for the COOH terminus of
LAR and PTPs (320), the NH2 terminus of PTPs (322), or the
COOH terminus of the LAR E subunit (aLAREC). Arrows at the
right indicate the position of the LAR or PTPs subunits. 
Figure 6. Schematic representation of the calcium ionophore-induced cleavage site of PTPs in comparison to the corresponding LAR
sequence. Shown are the amino acid sequences of PTPs (amino acids 817–836) and LAR (amino acids 1224–1242). The putative trans-
membrane regions are boxed, and identical amino acids of both PTPases are indicated by asterisks. The determined NH2-terminal se-
quence of the PTPs processing product is aligned to the homologous PTPs sequence, and the cleavage site is shown by an arrow.The Journal of Cell Biology, Volume 138, 1997 688
of the cells to the glass surface (data not shown). Consis-
tent with previous findings for LAR (Serra-Pages et al.,
1995), these structures are likely to represent adhesion
plaques. In addition, a punctate label along the contact
sites of neighboring cells was detected by labeling either
the extracellular domain of LAR (Fig. 7 A) and PTPs
(Fig. 7 B) or the intracellular domain of both PTPases
(Fig. 7, C and D). When cells were grown at low density
before cell–cell contacts were formed, labeling was found
as punctate staining along the cell membrane (Fig. 7 C).
Focal concentration of fluorescence was detected at inter-
cellular junctions as soon as these had formed between
cells at higher density (Fig. 7 D).
Treatment of the cells with EGTA alone (Fig. 7 E) or
subsequent incubation with ionophore (Fig. 7 F), which
did not lead to inducible processing of the PTPases (Fig.
3), induced internalization of the intracellular domains of
the PTPases. Here fluorescent label was detected as a ring-
shaped structure in the perinuclear cytosol, whereas pre-
fixation treatment with ionophore resulted in an internal-
ization of the fluorescence and an even cytosolic staining
of the intracellular domains of the PTPases (Fig. 7 G). Sig-
nificant labeling with antibodies directed against the extra-
cellular domains of the PTPases could no longer be detected
in ionophore-treated cells (data not shown). Incubation
with TPA was associated with only a partial internaliza-
tion of the P subunits, while a significant fluorescence re-
mained localized in the plasma membrane (Fig. 7 H). Con-
centration of this label at sites of cell–cell contact is
reduced in comparison to nontreated cells (Fig. 7 D).
The extent of proteolytic processing after treatment of
A431 cells with ionophore or TPA (Figs. 3–5) was paral-
leled by an internalization of the intracellular domains of
the PTPases, whereas the extracellular domains, as ex-
pected, could no longer be detected at the cell surface.
EGTA-induced internalization was not paralleled by pro-
teolytic processing of the PTPases and was therefore dis-
tinct from ionophore and TPA-induced internalization.
Surface Morphology of Intercellular Junctions
The localization of LAR and PTPs at cell–cell contacts
and their partial or complete internalization raised the
question whether and how EGTA, ionophore, and TPA
had affected the structural integrity of these specialized
membrane regions. On scanning electron microscopy, un-
treated and vehicle (DMSO)-treated A431 cells were
found to have formed multiple adhesion complexes be-
tween neighboring cells (Fig. 8, A and B). Incubation with
EGTA (Fig. 8 C), as well as subsequent treatment with
ionophore (Fig. 8 D) or ionophore alone (Fig. 8 E) in-
duced an almost complete disruption of intercellular junc-
tions, the formation of multiple surface protrusions, and a
rounded elevation of the normally flat cell body from the
surface. 40 min of treatment with TPA, which was also as-
sociated with internalization of LAR and PTPs on immu-
nolabeling studies (Fig. 7 H), left the junctional morphol-
ogy completely intact (Fig. 8 F). These observations
indicated that only the EGTA- and ionophore-induced in-
ternalization was paralleled by a structural disruption of
intercellular adhesions, whereas TPA-induced internaliza-
tion occurred independently of this effect.
Figure 7. Localization of LAR and PTPs. A431 cells were grown
on glass coverslips, fixed, and labeled for laser confocal micros-
copy, as indicated in Materials and Methods. A–D are represen-
tative of unstimulated control cells. E–H were treated as follows:
(E) 5 mM EGTA for 45 min; (F) EGTA (5 mM) for 45 min plus
A23187 (1025 M) for the last 30 min; (G) A23187 (1025 M) for 30
min; (H) TPA 1 mM for 40 min. Antibodies were (A) a LAREN
(NH2 terminus of LAR), (B) 322 (NH2 terminus of PTPs), (C–
H) 320 (COOH terminus of LAR and PTPs). Note the concen-
tration of the label along the cell–cell contact sites in A, B, and D
and the punctate staining along the circumference of solitary cells
(C). EGTA induced a ring-shaped core of internalized fluores-
cent label (E and F). Ionophore treatment (G) resulted in an
even cytosolic distribution of antibody labeling. After TPA treat-
ment, some dot-like fluorescence was detected in the cytosol, but
predominant labeling remained at intercellular junctions. Bar, 25 mm.
Intracellular Localization of LAR and PTPs
To study whether the two transmembrane PTPases are as-
sociated with any specific subcellular site, we analyzed
their localization in A431 cells by immunolabeling and flu-
orescence laser confocal microscopy. LAR- and PTPs-
specific labeling with either antibodies directed against the
intracellular or the extracellular domains of both PTPases
was observed in dot-like structures at the attachment sitesAicher et al. PTPs and LAR Processing 689
Colocalization of LAR and PTPs with Plakoglobin
We used antibodies directed against plakoglobin (g-cate-
nin), a protein localized at the intracellular site of adher-
ens junctions and desmosomes (Cowin et al., 1986), to
study whether LAR and PTPs colocalize to these special-
ized areas and to investigate whether the internalization of
the phosphatases from the plasma membrane is paralleled
by a dissociation of plakoglobin from this site. Plakoglobin
(Fig. 9 A) was detected along cell–cell contacts of neigh-
boring A431 cells, strongly colocalized with antiserum 320
label (Fig. 9 B), and therefore identified the subcellular
site of LAR and PTPs as adherens junctions and desmo-
somes. Upon ionophore treatment, plakoglobin (Fig. 9 C)
and the phosphatase domains were internalized in parallel
from the rapidly dissociating intercellular junctions (Fig. 9
D). Incubation with TPA for 40 min left the localization of
anti-plakoglobin labeling unaffected (Fig. 9 E) but in-
duced a significant yet incomplete internalization of 320
label (Fig. 9 F). Extended time course experiments with
TPA treatment up to 4 h showed that plakoglobin, in agree-
ment with studies by Fabre and DeHerreros (1993), is re-
distributed from the plasma membrane to the cytosol (Fig.
9 G), although at a much slower rate and not in parallel
with the intracellular phosphatase domain (Fig. 9 H).
When antibodies directed against the extracellular do-
mains of LAR and PTPs were used for immunolabeling,
both ionophore treatment and TPA incubation induced a
complete disappearance of fluorescence label (data not
shown).
These data indicated that LAR and PTPs colocalized
with plakoglobin to adherens junctions and desmosomes.
The subsequent internalization of the intracellular phos-
phatase domains occurred rapidly and in parallel with pla-
koglobin after ionophore stimulation. TPA-induced inter-
nalization of plakoglobin occurred at much longer treatment
intervals and not in parallel with that observed for the P
subunits of the PTPases.
Figure 8. Surface morphol-
ogy of intercellular adhe-
sions. A431 cells were fixed
and prepared for scanning
electron microscopy as de-
scribed in Materials and
Methods. Prefixation treat-
ment was as follows: (A) con-
trol; (B) vehicle (DMSO);
(C) EGTA (5 mM) for 45
min; (D) EGTA (5 mM) for
45 min plus A23187 (1025 M)
for the last 30 min; (E)
A23187 (1025 M) for 30 min;
(F) TPA (1 mM) for 40 min.
Note intact cell–cell contacts
in A, B, and F and largely dis-
rupted intercellular junctions
in  C,  D, and E. Bar, 10 mm.The Journal of Cell Biology, Volume 138, 1997 690
Figure 9. Colocalization of
LAR and PTPs with plakoglo-
bin after ionophore and TPA
treatment. A431 cells were
fixed and labeled for plakoglo-
bin (A, C, E, and G) or double
labeled with anti-plakoglobin
and antiserum 320 (COOH
terminus of LAR and PTPs;
B,  D,  F, and H) as described in
Materials and Methods. Laser
confocal fluorescence images
were superimposed on a trans-
mission image to show protein
localization together with cel-
lular and junctional morphol-
ogy. Red pseudocolor indicates
monoclonal anti-plakoglobin
antibody; green, polyclonal
320 antiserum; and yellow, re-
gions of colocalization of both.
Prefixation treatment was as
follows: (A and B) controls; (C
and  D) A23187 (1025 M) for
30 min; (E and F) TPA (1 mM)
for 40 min; (G and H) TPA (1
mM) for 240 min. Note rapid
internalization of label and
disruption of cell–cell contacts
in C and D. While 40 min of
TPA neither disrupted inter-
cellular junctions nor altered
plakoglobin localization (E),
antibody 320 label was already
found in the cytosol (F). After
4 h of TPA treatment, signifi-
cant plakoglobin label (G) and
even more antibody 320 label
(H) were found internalized in
comparison to the label remain-
ing at the plasma membrane or
at cell–cell adhesions. Bar, 25 mm. Aicher et al. PTPs and LAR Processing 691
Figure 10. Colocalization of
LAR and PTPs with plakoglo-
bin after EGTA treatment.
Cells were prepared, labeled,
and imaged as indicated in Fig.
9, legend. Prefixation treat-
ment was EGTA (5 mM) for
45 min (A, C, E, and G) and
EGTA (5 mM) for 240 min (B,
D,  F, and H). Cells were la-
beled with anti-plakoglobin
antibody (A and B), anti-pla-
koglobin antibody plus antise-
rum 320 (C and D), antiserum
aLAREN (NH2 terminus of
LAR;  E),  aLAREN plus anti-
plakoglobin antibody (G), an-
tiserum 322 (NH2 terminus of
PTPs; F), and 322 plus anti-
plakoglobin antibody (H).
Note that EGTA treatment in-
duces rapid disruption of inter-
cellular junction and internal-
ization of plakoglobin (A and
B) together with the intracellu-
lar phosphatase domain (C
and  D) from the plasma mem-
brane. EGTA also induces in-
ternalization of the extracellu-
lar E subunits of the PTPases
(E and F), which can be colo-
calized with plakoglobin (G
and  H). Bar, 25 mm.The Journal of Cell Biology, Volume 138, 1997 692
Localization of LAR and PTPs after EGTA Treatment
The previous experiments demonstrated that the TPA-
induced shedding of the E subunit and the internalization
of the P subunit of LAR and PTPs could occur in the pres-
ence of intact cell–cell adhesions. Whether, however, the
disruption of cell–cell contacts is automatically associated
with internalization of the P subunit remained unknown.
We showed in Fig. 7, that EGTA induced a rapid and al-
most complete disruption of intercellular junctions, which
should lead to the dissociation of protein complexes at
these subcellular sites (Kartenbeck et al., 1991). Plakoglo-
bin label in A431 cells was indeed found in the cytosol un-
der the plasma membrane after 45 min of EGTA treat-
ment (Fig. 10 A) and in the perinuclear cytosol after 4 h
EGTA (Fig. 10 B). Colocalization with the intracellular
domains of LAR and PTPs demonstrated the same route
of redistribution from the membrane to the cytosol (Fig.
10, C and D). Immunofluorescent staining with LAR and
PTPs antibodies directed against the extracellular domain
alone (Fig. 10, E and F) or in colocalization with plakoglo-
bin (Fig. 10, G and H) resulted in exactly the same appear-
ance as observed for the intracellular domains of the PTP-
ases. Shown here is the 45-min treatment for LAR (Fig.
10, E and G) and the 4-h treatment for PTPs (Fig. 10, F
and H). Immunofluorescent labeling at other time points
was identical for both PTPases (data not shown).
In contrast to ionophore and TPA treatment, the disrup-
tion of intercellular junctions by EGTA did not induce
shedding of the E subunits but instead led to an internal-
ization of the intracellular as well as the extracellular part
of LAR and PTPs. The previously mentioned experi-
ments showed that this redistribution occurred without
prior proteolytic cleavage of LAR and PTPs and could
therefore involve the entire and intact molecule.
In Vitro Association of LAR with Proteins of
the Cell Adhesion Complexes in Adherens Junctions 
and Desmosomes
To determine whether the PTPases not only localize to ad-
herens junctions and desmosomes but can also associate
with known proteins of the cell adhesion complexes at
these sites, we performed in vitro association experiments.
E-cadherin, a- and b-catenin, and plakoglobin were tran-
siently expressed in 293 cells. Cells were incubated with or
without the phosphatase inhibitor pervanadate before ly-
sis to study the influence of tyrosine phosphorylation of
these proteins on the association with LAR. Lysates were
then incubated with glutathione-sepharose–bound GST-
fusion protein, GST–hPTP-LARi, containing the entire in-
tracellular domain of LAR, from amino acids 1,259 to
1,881. Bound proteins were analyzed by immunoblotting
with antibodies directed against b-catenin (Fig. 11 A), pla-
koglobin (Fig. 11 B), a-catenin (data not shown), and E-cad-
herin (data not shown). 
Association of b-catenin (Fig. 11 A) and plakoglobin
(Fig. 11 B) with the GST-fusion protein, GST–hPTP-
LARi, was detected in lysates of cells that expressed these
proteins but was absent in controls. The amounts of associ-
ated proteins were independent of prior pervanadate
treatment of the cells. In contrast, no specific association
could be observed with lysates from a-catenin- or E-cad-
herin–expressing cells (data not shown), even though
overexpression of these proteins in 293 cells was con-
firmed by immunoblotting of the same lysates with the ap-
propiate antibodies (data not shown).
The observed, direct in vitro association between the in-
tracellular domain of LAR with plakoglobin and b-catenin
suggests that LAR not only colocalized with cell adhesion
molecules at sites of cell–cell contact but that these proteins
also interact in a functional manner. However, the ques-
tion whether plakoglobin and b-catenin represent physio-
logical targets of LAR could not be answered, because
Figure 11. In vitro association of LAR with plakoglobin and b-catenin. b-catenin and plakoglobin were transiently expressed in 293
cells, and cells were stimulated for 10 min with pervanadate before lysis. Equal amounts of lysates were incubated with the LAR–GST-
fusion protein, GST–hPTP LARi, or a threefold molar excess of GST, complexes were immobilized on glutathione–sepharose, and pre-
cipitates were separated by SDS-PAGE. Lysates of control plasmid-transfected 293 cells were bound in the same way to GST–hPTP
LARi-glutathione–sepharose. Bound proteins were analyzed by immunoblotting with antibodies specific for b-catenin (A) or plakoglo-
bin (B). Arrows indicate the proteins of interest; molecular size standards in kD are shown on the left.Aicher et al. PTPs and LAR Processing 693
under our experimental conditions the association was in-
dependent of tyrosine phosphorylation of these proteins.
Discussion
We compared structural and functional characteristics of
the highly related PTPases LAR and PTPs in regard to
spontaneous as well as induced proteolytic processing. In
analogy to LAR (Streuli et al., 1992; Yu et al., 1992) and
other members of the type II class of PTPases (Jiang et al.,
1993; Brady-Kalnay and Tonks, 1994; Pulido et al., 1995a;
Fuchs et al., 1996), PTPs was expressed in two subunits
that were derived from a precursor protein by proteolytic
processing. The similarities in the sequence as well as the
structure among the members of this subfamily of PTPases
suggest that they may also have closely related functions.
This assumption is further supported by the observation
that both (LAR and PTPs) underwent analogous process-
ing in response to intracellular calcium concentration in-
crease or in response to treatment with TPA. Interestingly,
while TPA-induced processing of overexpressed LAR re-
quired co-overexpression of PKCa in 293 cells, this was
not necessary for PTPs, suggesting differential effector
sensitivity of the two PTPases. In 293 cells that overex-
pressed LAR or PTPs as well as in cell lines that ex-
pressed these PTPases endogenously, the inducible pro-
cessing took place at the NH2 terminus of the P subunit
removing a 14-kD fragment from LAR and an 8-kD frag-
ment from PTPs. It also resulted in shedding of the E sub-
units of both PTPases. By NH2-terminal sequencing we
identified the cleavage site of PTPs and found it to be lo-
cated between amino acids Pro821 and Ile822, which corre-
sponds to a distance of merely six amino acids from the
transmembrane region. The analogous cleavage position
of LAR does not show any sequence homology to that of
PTPs. Because the E subunit of LAR could be detected in
the cellular supernatant after proteolytic processing, the
cleavage of LAR also occurred extracellulary. Serra-Pages
et al. (1994) have already demonstrated by mutational
analysis that the cleavage of LAR in response to TPA oc-
curred at a site that is located COOH-terminally to amino
acid 1,222. Despite the absence of any sequence homology
to the cleavage site of PTPs, the proteolytic processing of
LAR therefore occurred in a completely analogous posi-
tion that is located between amino acids 1,222 and the first
amino acid of the transmembrane region, Met1235.
Solubilization of extracellular domains of transmem-
brane proteins by proteolytic processing has been ob-
served for several transmembrane proteins (for review see
Ehlers and Riordan, 1991). The exact cleavage sites, how-
ever, are in most cases not characterized. The transmem-
brane molecules that have been most thoroughly investi-
gated are those growth factors that are released as soluble
proteins by proteolytic processing from a transmembrane
proprotein. The cleavage sites of these different growth
factors also show no significant sequence homology but
display clusters of small nonpolar amino acids (for review
see Massague and Pandiella, 1993). The same enrichment
of nonpolar amino acids was found in the cleavage posi-
tion of PTPs. While proteases responsible for the shed-
ding of extracellular domains of transmembrane proteins
have not been identified, a protease activity involved in
the proprotein processing of TGFa had been character-
ized. It is a transmembrane protease whose active center
was shown to be located in its extracellular part (Harano
and Mizuno, 1994). Since the cleavage of the TGFa pro-
protein could be activated by TPA and A23187 (Pandiella
and Massague, 1991), the same agents that we used to in-
duce the processing of LAR and PTPs, the transmem-
brane character of this protease can serve as a model for
the mechanisms that allow intracellular signals to increase
the extracellular activity of an enzyme. For the proprotein
processing of TGFa, as opposed to the processing of the
PTPases, the presence of a COOH-terminal valin residue
in the short intracellular domain was an essential require-
ment (Bosenberg et al., 1992). While we cannot conclude
from our study that the same or a related protease medi-
ated the inducible processing of LAR and PTPs, we ex-
cluded the possibility that the protease calpain, which me-
diated the processing of the intracellular PTPase 1B (Frangioni
et al., 1993) was involved here. We therefore suggest that
the processing of LAR and PTPs underlies a different
mechanism and is distinct from the processing of PTP1B.
The observation that the characteristics as well as the
size of the resulting cleavage proteins were comparable in
all the cell lines we studied indicated that the processing of
LAR and PTPs was a specific process and a ubiquitous
event in cell lines of different origins. Moreover, the fact
that a solubilization of the E subunits could also be ob-
served for PTPm (Gebbink et al., 1995) and PTPd (Pulido
et al., 1995a) suggested that this form of processing could
be a general feature of type II PTPases. The cell density-
dependent shedding of the E subunit of LAR has been
proposed to play a role in the contact inhibition of cell
growth (Streuli et al., 1992). The latter report and a study
by Serra-Pages et al. (1994) showed that the shedding of
the E subunits of PTPases in response to high cell density
was caused by proteolytic processing. A cell density-
dependent increase in the catalytic activity of PTPases was
observed in contact-inhibited fibroblasts (Pallen and Tong,
1991) as well as in A431 cells (Mansbridge et al., 1992),
while the phosphatase inhibitor vanadate was found to
abolish the contact inhibition of rat kidney cells under cer-
tain experimental conditions (Rijksen et al., 1993). The
underlying mechanism, however, through which the pro-
cessing of transmembrane PTPases participates in cell
contact inhibition is not yet understood. An increase of
phosphatase expression with growing cell density has been
observed for some PTPases (Longo et al., 1993; Östman et
al., 1994; Celler et al., 1995; Fuchs et al., 1996). Cleavage
and subsequent loss of the extracellular domains from re-
ceptor-type PTPases could also contribute to increased
phosphatase activity. This hypothesis was supported by
the observation that incubation of fibroblasts with trypsin,
a treatment that permitted the cleavage of extracellular do-
mains from transmembrane proteins, increased the phos-
phatase activity in these cells (Maher, 1993). However, in
our study neither the in vitro activity of the processed P
subunits of LAR and PTPs nor their activity towards pos-
sible substrates, such as receptor tyrosine kinases, was found
to be altered in cotransfection studies (data not shown).
To explore putative biological targets for the cleaved
PTPases, we studied how the inducible processing would
affect the subcellular localization of LAR and PTPs andThe Journal of Cell Biology, Volume 138, 1997 694
used confocal microscopy in conjunction with cells that en-
dogenously express both proteins. In untreated A431 cells,
LAR and PTPs were found at focal cell substratum adhe-
sions (data not shown; Serra-Pages et al., 1995) as well as
at sites of cell–cell contacts. The colocalization with plako-
globin (Cowin et al., 1986) identified these structures as
adherens junctions and desmosomes. These subcellular
compartments are known to contain cell adhesion mole-
cules of the cadherin/catenin family, which mediate cell–
cell adhesion by a homologous, calcium-dependent inter-
action of their extracellular domains and by linking the
cell contact sites to the cytoskeleton via proteins bound to
their intracellular portion (for reviews see Grunwald,
1993; Koch and Franke, 1994). Increased tyrosine phos-
phorylation at the sites of cell–cell and cell–substratum ad-
hesions correlated with a number of biological processes
such as cell migration, malignant transformation, and met-
astatic spread of tumor cells (for reviews see Kemler, 1993;
Clark and Brugge, 1995; Rosales et al., 1995). The close as-
sociation between cell contact disruption and malignant
behavior actually led to the conclusion that cadherins rep-
resent a separate class of tumor suppressors (Birchmeier
et al., 1995). We now show here that LAR and PTPs colo-
calize with cell adhesion proteins at sites of cell–cell con-
tact, an observation that suggests that LAR and PTPs may
be involved in either the formation or maintenance of in-
tercellular junctions. This is further supported by the di-
rect association of plakogobin and b-catenin with a GST-
fusion protein of the intracellular domain of LAR in vitro.
Although this association was found to be independent of
tyrosine phosphorylation of plakogobin and b-catenin, we
cannot rule out that phosphorylation plays a role for the in
vivo interaction of PTPases with these proteins. An associ-
ation of proteins of the cadherin/catenin complex was not
only reported for PTPases of the LAR family (Kypta et
al., 1996) but also for two other members of class II PTP-
ases, PTPk (Fuchs et al., 1996) and PTPm (Brady-Kalnay
et al., 1995). These two PTPases (Brady-Kalnay et al.,
1995; Gebbink et al., 1995; Fuchs et al., 1996) and PCP-2
(Wang et al., 1996) also localized to sites of cell–cell con-
tacts. However, the linkage of LAR to focal cell–substra-
tum adhesions via interaction with the protein LIP-1
(Serra-Pages et al., 1995) and the association of PTPs with
LIP-1 (Pulido et al., 1995b) make it likely that the sup-
posed regulation of cadherin/catenin complexes is not the
only function of LAR and PTPs.
When we analyzed the consequences of proteolytic pro-
cessing on the subcellular localization of LAR and PTPs
we found that the treatment with either TPA or A23187
resulted in a loss of labeling for the extracellular domain.
This finding was in complete agreement with the cleavage
and shedding of the E subunits of both PTPases, which we
observed in biochemical experiments. The effect, how-
ever, that these agents showed on the localization of the
shortened P subunit of LAR and PTPs was quite differ-
ent. A23187, while inducing a complete disruption of cell–
cell contacts within minutes, led to an even cytosolic distri-
bution of the P subunits and a loss of labeling at the cell
membrane. A brief treatment with TPA, on the other
hand, left cell–cell contacts morphologically intact but re-
duced the concentration of P subunits at these cell–cell
contacts by inducing only a partial internalization of label
to the cytosol. After longer treatment intervals with TPA,
a structural disturbance of cell–cell adhesions was finally
observed and was paralleled by a greater internalization of
P subunits. Interestingly, a depletion of calcium in the cul-
ture medium with EGTA also resulted in an internaliza-
tion of both PTPases. This effect, however, occurred inde-
pendent of proteolytic processing, was not associated with
a shedding of E subunits, and involved both subunits of
the presumably intact PTPases.
Based upon these observations, we conclude that at
least two independent mechanisms for the internalization
of LAR and PTPs exist. One of them involves the induc-
tion of proteolytic processing, which, as demonstrated in
the TPA experiments, can lead to internalization of P sub-
units even in the presence of intact cell–cell contact. The
other mechanism involves the disruption of cell–cell con-
tact but, as shown in the EGTA experiments, can lead to
internalization of the intact PTPases without prior pro-
teolytic processing.
The proteins of the cadherin/catenin complexes at focal
cell–cell contacts underwent a very similar internalization
and, later, degradation when cells were treated with
EGTA (Kartenbeck et al., 1991) or TPA (Fabre and De
Herreros, 1993). However, the time course of internaliza-
tion for plakoglobin and the PTPases differed in our ex-
periments and were dependent on the agent used. Whereas
short-time treatment with TPA left the integrity of inter-
cellular junctions and the localization of plakoglobin unaf-
fected, it already induced a significant yet incomplete in-
ternalization of the PTPases. At longer periods of incubation,
intercellular junctions became more and more disrupted,
and plakoglobin was also redistributed from the plasma
membrane to the cytosol, but not in parallel and at a much
slower rate than the intracellular phosphatase domains. In
contrast to the effect observed with TPA, ionophore and
EGTA, two agents that disrupted cell–cell contacts, in-
duced a rapid and simultaneous internalization of both
plakoglobin and the intracellular PTPase domains. We
conclude from these data that the agents that we have
shown to disrupt intercellular junctions simultaneously in-
duce the internalization of LAR and PTPs and disturb the
integrity of the cadherin/catenin complexes at the same
subcellular sites. With TPA, on the other hand, the inter-
nalization of the PTPases occured before the integrity of
cellular junctions was affected, and the loss of the PTPases
at these subcellular sites presumably contributes to the
later disruption of cell–cell contacts.
LAR and PTPs did not only colocalize with cell adhe-
sion proteins of the cadherin/catenin family and were sub-
jected to a comparable intracellular redistribution under
experimental conditions, but also their extracellular do-
mains were shed in a manner that was also reported for
cadherins (Wheelock et al., 1987; Roark et al., 1992). In-
terestingly, the soluble extracellular domain of N-cad-
herin, NCAD90, remained capable of binding N-cadherin
in a homophilic manner and promoted cell adhesion and
neurite growth in chicken embryo retina cells when pre-
sented in a substrate-bound form (Paradies and Grunwald,
1993). Moreover, the soluble extracellular domain of
E-cadherin was able to inhibit cell adhesion (Wheelock et
al., 1987). It is therefore possible that the extracellular do-
mains of receptor-type PTPases, which are also cleavedAicher et al. PTPs and LAR Processing 695
from the cell surface upon proteolytic processing, could be
equally involved in the formation, maintenance, or resto-
ration of cell adhesions. While the distinct subcellular re-
distribution of presumably catalytically active P subunits
of LAR and PTPs under normal conditions may regulate
proliferation and tissue integrity by cell–cell contact
through targeting the phosphatase activity to specific in-
tracellular sites, the biological function of the solubilized E
subunits remains at present unknown. Under pathophysio-
logical conditions such as malignant cell transformation,
the regulatory mechanism investigated here may represent
a critical target for subversion leading to dysregulated
growth and metastatic spread.
We thank Y. Schlessinger for providing the expression vector pRK5-PTPs
and antisera 320 and 322, H. Saito for providing LAR cDNA as plasmid
pSP65-LAR, J. Murphy and R. Aebrecht for advice and support with con-
focal microscopy, A. Kharitonenkov for helpful discussions, and K. Mar-
tell for critically reading the manuscript. 
This work was supported by a grant from SUGEN, INC.
Received for publication 5 December 1996 and in revised form 18 April
1997.
References
Birchmeier, W., J. Hülsken, and J. Behrens. 1995. E-Cadherin as an invasion
suppressor. Ciba Found. Symp. 189:124–141.
Bosenberg, M.W., A. Pandiella, and J. Massague. 1992. The cytoplasmic car-
boxy-terminal amino acid specifies cleavage of membrane TGFa into solu-
ble growth factor. Cell. 71:1157–1165.
Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of mi-
crogram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem. 72:284–254.
Brady-Kalnay, S.M., and N.K. Tonks. 1994. Identification of the homophilic
binding site of the receptor protein tyrosine phosphatase PTPm. J. Biol.
Chem. 269:28472–28477.
Brady-Kalnay, S.M., and N.K. Tonks. 1995. Protein tyrosine phosphatases as
adhesion receptors. Curr. Opin. Cell Biol. 7:650–657.
Brady-Kalnay, S.M., A.J. Flint, and N.K. Tonks. 1993. Homophilic binding of
PTPm, a receptor-type protein tyrosine phosphatase, can mediate cell–cell
aggregation. J. Cell Biol. 122:961–972.
Brady-Kalnay, S.M., D.L. Rimm, and N.K. Tonks. 1995. Receptor protein ty-
rosine phosphatase PTPm associates with cadherins and catenins in vivo. J.
Cell Biol. 130:977–986. 
Celler, J.W., X. Luo, L.J. Gonez, and F.D. Böhmer. 1995. mRNA expression of
two transmembrane protein tyrosine phosphatases is modulated by growth
factors and growth arrest in 3T3 fibroblasts. Biochem. Biophys. Res. Com-
mun. 209:614–621.
Charbonneau, H., and N.K. Tonks. 1992. 1002 protein phosphatases. Annu.
Rev. Cell Biol. 8:463–493.
Chen, C., and H. Okayama. 1987. High-efficiency transformation of mamma-
lian cells by plasmid DNA. Mol. Cell. Biol. 7:2745–2752.
Clark, E.A., and J.S. Brugge. 1995. Integrins and signal transduction pathways:
the road taken. Science (Wash. DC). 268:233–239.
Cowin, P., H.P. Kapprell, W.W. Franke, J. Tamkun, and R.O. Hynes. 1986. Pla-
koglobin: a protein common to different kinds of intracellular adhering junc-
tions. Cell. 46:1063–1073.
Eaton, D.L., W.I. Wood, D. Eaton, P.E. Hass, P. Hollingshead, K. Wion, J.
Mather, R.M. Lawn, G.A. Vehar, and C. Gorman. 1986. Construction and
characterization of an active factor VIII variant lacking the central one-third
of the molecule. Biochemistry. 25:8343–8347.
Ehlers, M.R.W., and J.F. Riordan. 1991. Membrane proteins with soluble coun-
terparts: role of proteolysis in the release of transmembrane proteins. Bio-
chemistry. 30:10065–10074.
Fabre, M., and A.G. De Herreros. 1993. Phorbol ester-induced scattering of
HT-29 human intestinal cancer cells is associated with down-modulation of
E-cadherin. J. Cell Sci. 106:513–522.
Frangioni, J.V., A. Oda, M. Smith, E.W. Salzman, and B.G. Neel. 1993.
Calpain-catalyzed cleavage and subcellular relocation of protein phosphoty-
rosine phosphatase 1B (PTP-1B) in human platelets. EMBO (Eur. Mol.
Biol. Organ.) J. 12:4843–4856.
Fuchs, M., T. Müller, M.M. Lerch, and A. Ullrich. 1996. Association of human
protein-tyrosine phosphatase k with members of the armadillo family. J.
Biol. Chem. 271:16712–16719.
Gebbink, M.F.B.G., I. Van Etten, G. Hatebor, R. Suijkerbuijk, R.L. Beijersber-
gen, A.G. Van Kessel, and W.H. Moolenaar. 1991. Cloning, expression and
chromosomal localization of a new putative receptor-like protein tyrosine
phosphatase. FEBS (Fed. Eur. Biol. Soc.) Lett. 290:123–130.
Gebbink, M.F.B.G., G.C.M. Zondag, R.W. Wubbolts, R.L. Beijersbergen, I.
Van Etten, and W.H. Moolenaar. 1993. Cell–cell adhesion mediated by a re-
ceptor-like protein tyrosine phosphatase. J. Biol. Chem. 268:16101–16104.
Gebbink, M.F.B.G., G.C.M. Zondag, G.M. Koningstein, E. Feiken, R.W. Wub-
bolts, and W.H. Moolenaar. 1995. Cell surface expression of receptor pro-
tein tyrosine phosphatase RPTPm is regulated by cell–cell contact. J. Cell
Biol. 131:251–260.
Green, H., and O. Kehinde. 1974. Sublines of mouse 3T3 cells that accumulate
lipid. Cell. 1:113–115.
Grunwald, G.B. 1993. The structural and functional analysis of cadherin cal-
cium-dependent cell adhesion molecules. Curr. Opin. Cell Biol. 5:797–805.
Harano, T., and K. Mizuno. 1994. Phorbol ester-induced activation of a mem-
brane-bound candidate protransforming growth factor-a processing enzyme.
J. Biol. Chem. 20305–20311.
Jiang, Y.P., H. Wang, P. D’Eustachio, J.M. Musacchio, J. Schlessinger, and J.
Sap. (1993). Cloning and characterization of R-PTP-k, a new member of the
receptor protein tyrosine phosphatase family with a proteolytically cleaved
cellular adhesion molecule-like extracellular region. Mol. Cell. Biol. 13:
2942–2951.
Kartenbeck, J., M. Schmelz, W.W. Franke, and B. Geiger. 1991. Endocytosis of
junctional cadherins in bovine kidney epithelial (MDBK) cells cultured in
low Ca21 medium. J. Cell Biol. 113:881–892.
Kemler, R. 1993. From cadherins to catenins: cytoplasmic protein interactions
and regulation of cell adhesion. Trends Genet. 9:317–321.
Koch, P.J., and W.W. Franke. 1994. Desmosomal cadherins: another growing
multigene family of adhesion molecules. Curr. Opin. Cell Biol. 6:682–687.
Krueger, N.X., M. Streuli, and H. Saito. 1990. Structural diversity and evolution
of human receptor-like protein tyrosine phosphatases. EMBO (Eur. Mol.
Biol. Organ.) J. 9:3241–3252.
Kypta, R.M., H. Su, and L.F. Reichardt. 1996. Association between a trans-
membrane protein tyrosine phosphatase and the cadherin–catenin complex.
J. Cell Biol. 134:1519–1529.
Longo, F.M., J.A. Martignetti, J.M. Le Beau, J.S. Zhang, J.P. Barnes, and J.
Brosius. 1993. Leukocyte common antigen-related receptor-linked tyrosine
phosphatase. Regulation of mRNA expression. J. Biol. Chem. 268:26503–
26511.
Maher, P.A. 1993. Activation of phosphotyrosine phosphatase activity by re-
duction of cell–substrate adhesion. Proc. Natl. Acad. Sci. USA. 90:11177–
11181.
Mansbridge, J.N., R. Knvechel, A.M. Knapp, and R.M. Sutherland. 1992. Im-
portance of tyrosine phosphatases in the effects of cell-cell contact and mi-
croenvironments on EGF-stimulated tyrosine phosphorylation. J. Cell.
Physiol. 433–442.
Massague, J., and A. Pandiella. 1993. Membrane-anchored growth factors.
Annu. Rev. Biochem. 62:515–541.
Mizuno, K., K. Hasegawa, T. Katagiri, M. Ogimoto, T. Ichikawa, and H.
Yakura. 1993. MPTPd, a putative murine homolog of HPTPd, is expressed in
specialized regions of the brain and in the B-cell lineage. Mol. Cell. Biol. 13:
5513–5523.
O’Grady, P., N.X. Krueger, M. Streuli, and H. Saito. 1994. Genomic organiza-
tion of the human LAR protein tyrosine phosphatase gene and alternative
splicing in the extracellular fibronectin type-III domains. J. Biol. Chem. 269:
25193–25199.
Ogata, M., M. Sawada, A. Kosugi, and T. Hamaoka. 1994. Developmentally
regulated expression of a murine receptor-type protein tyrosine phosphatase
in the thymus. J. Immunol. 153:4478–4487.
Östman, A., Q. Yang, and N.K. Tonks. 1994. Expression of DEP-1, a receptor-
like protein-tyrosine-phosphatase, is enhanced with increasing cell density.
Proc. Natl. Acad. Sci. USA. 91:9680–9684.
Pallen, C.J., and P.H. Tong. 1991. Elevation of membrane tyrosine phosphatase
activity in density-dependent growth-arrested fibroblasts. Proc. Natl. Acad.
Sci. USA. 88:6996–7000.
Pan, M.G., C. Rim, K.P. Lu, T. Florio, and P.J.S. Storck. 1993. Cloning and ex-
pression of two structurally distinct receptor-linked protein-tyrosine phos-
phatases generated by RNA processing from a single gene. J. Biol. Chem.
268:19284–19291.
Pandiella, A., and J. Massague. 1991. Multiple signals activate cleavage of the
membrane transforming growth factor-a precursor. J. Biol. Chem. 266:5769–
5773.
Paradies, N.E., and G.B. Grunwald. 1993. Purification and characterization of
NCAD90, a soluble endogenous form of N-cadherin, which is generated by
proteolysis during retinal development and retains adhesive and neurite-
promoting function. J. Neurosci. Res. 36:33–45.
Pot, D.A., T.A. Woodford, E. Remboutsika, R.S. Haun, and J.E. Dixon. 1991.
Cloning, bacterial expression, purification, and characterization of the cyto-
plasmic domain of rat LAR, a receptor-like protein tyrosine phosphatase. J.
Biol. Chem. 266:19688–19696.
Pulido, R., N.X. Krueger, C. Serra-Pages, H. Saito, and M. Streuli. 1995a. Mo-
lecular characterization of the human transmembrane protein-tyrosine phos-
phatase d. J. Biol. Chem. 270:1–7.
Pulido, R., C. Serra-Pages, M. Tang, and M. Streuli. 1995b. The LAR/PTPd/
PTPs subfamily of transmembrane protein-tyrosine-phosphatases: multiple
human LAR, PTPd, and PTPs isoforms are expressed in a tissue specific
manner and associate with the LAR-interacting protein LIP.1. Proc. Natl.The Journal of Cell Biology, Volume 138, 1997 696
Acad. Sci. USA. 92:11686–11690.
Rijksen, G., M.C.W. Völler, and E.J.J. Van Zoelen. 1993. Orthovanadate both
mimics and antagonizes the transforming growth factor b action on normal
rat kidney cells. J. Cell. Physiol. 154:393–401.
Roark, E.F., N.E. Paradies, L.A. Lagunowich, and G.B. Grunwald. 1992. Evi-
dence for endogenous proteases, mRNA level and insulin as multiple mech-
anisms of N-cadherin down-regulation during retinal development. Develop-
ment. 114:973–984.
Rosales, C., V. O’Brien, L. Kornberg, and R. Juliano. 1995. Signal transduction
by cell adhesion receptors. Biochim. Biophys. Acta. 1242:77–98.
Rotin, D., B.J. Goldstein, and C.A. Fladd. 1994. Expression of the tyrosine
phosphatase LAR-PTP2 is developmentally regulated in lung epithelia. Am.
J. Physiol. 267:263–270.
Sap, J., Y.P. Jiang, D. Friedlander, M. Grumet, and J. Schlessinger. 1994. Re-
ceptor tyrosine phosphatase R-PTP-k mediates homophilic binding. Mol.
Cell. Biol. 14:1–9.
Seedorf, K., M. Shearman, and A. Ullrich. 1995. Rapid and long term effects of
protein kinase C on receptor tyrosine kinase phosphorylation and degrada-
tion. J. Biol. Chem. 270:18953–18960.
Serra-Pages, C., H. Saito, and M. Streuli. 1994. Mutational analysis of propro-
tein processing, subunit association and shedding of the LAR transmem-
brane protein tyrosine phosphatase. J. Biol. Chem. 269:23632–23641.
Serra-Pages, C., N.L. Kedersha, L. Fazikas, M. Quintus, A. Debant, and M.
Streuli. 1995. The LAR transmembrane protein tyrosine phosphatase and a
coiled-coil LAR interacting protein co-localize at focal adhesions. EMBO
(Eur. Mol. Biol. Organ.) J. 14:2827–2838.
Smith, D.B., and K.S. Johnson. 1988. Single-step purification of polypeptides
expressed in Escherichia coli as fusions with glutathione-S-transferase. Gene
(Amst.). 67:31–40.
Streuli, M., N.X. Krueger, L.R. Hall, S.F. Schlossman, and H. Saito. 1988. A
new member of the immunoglobulin superfamily that has a cytoplasmic re-
gion homologous to the leucocyte common antigen. J. Exp. Med. 168:1553–
1562.
Streuli, M., N.X. Krueger, P.D. Ariniello, M. Tang, J.M. Munro, W.A. Blattler,
D.A. Adler, C.M. Disteche, and H. Saito. 1992. Expression of the receptor-
linked protein tyrosine phosphatase LAR: proteolytic cleavage and shed-
ding of the CAM-like extracellular region. EMBO (Eur. Mol. Biol. Organ.)
J. 11:897–907.
Tsujinaka, T., Y. Kajiwara, J. Kambayashi, M. Sakon, N. Higuchi, T. Tanaka,
and T. Mori. 1988. Synthesis of a new cell penetrating calpain inhibitor
(calpeptin).  Biochem. Biophys. Res. Comm. 153:1201–1208.
Walton, K.M., K.J. Martell, S.P. Kwak, J.E. Dixon, and B.L. Largent. 1993. A
novel receptor-type protein tyrosine phosphatase is expressed during neuro-
genesis in the olfactory neuroepithelium. Neuron. 11:387–400.
Wang, H., Z. Lian, M.M. Lerch, Z. Chen, W. Xie, and A. Ullrich. 1996. Charac-
terization of PCP-2, a novel receptor protein tyrosine phosphatase of the
MAM domain family. Oncogene. 12:2555–2562.
Wheelock, M.J., C.A. Buck, K.B. Bechtol, and C.H. Damsky. 1987. Soluble 80-
kd fragment of cell-CAM 120/80 disrupts cell–cell adhesion. J. Cell. Bio-
chem. 34:187–202.
Yan, H., A. Grossman, H. Wang, P. D’Eustachio, K. Mossie, J.M. Musacchio,
O. Silvennoinen, and J. Schlessinger. 1993. A novel receptor tyrosine phos-
phatase-s that is highly expressed in the nervous system. J. Biol. Chem. 268:
24880–24886.
Yu, Q., T. Lenardo, and R.A. Weinberg. 1992. The N-terminal and C-terminal
domains of a receptor tyrosine phosphatase are associated by non-covalent
linkage. Oncogene. 7:1051–1057.
Zhang, J.S., and F.M. Longo. 1995. LAR tyrosine phosphatase receptor: alter-
native splicing is preferential to the nervous system, coordinated with cell
growth and generates novel isoforms containing extensive CAG repeats. J.
Cell Biol. 3:415–431.
Zhang, W.R., N. Hashimoto, F. Ahmad, W. Ding, and B.J. Goldstein. 1994.
Molecular cloning and expression of a unique receptor-like protein-tyrosine
phosphatase in the leucocyte-common-antigen-related phosphatase family.
Biochem. J. 302:39–47.